Teva-losartan/hctz (2019-03-06)
Recall Summary Teva-Losartan/HCTZ, a blood pressure medication, has been recalled across Canada due to a product safety issue. The recall is classified as Class I, meaning there is a serious potential health risk. This recall affects all patients in Canada who have been prescribed this medication.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2019-03-06
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/a0f2a262-b569-454b-9b6c-92fd020bd303